S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 38,150
-200 (-0.52%)
At close: Feb 27, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 472.49 billion as of February 27, 2026. Its market cap has increased by 89.30% in one year.
Market Cap
472.49B
Enterprise Value
475.76B
Revenue
16.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
38,150.00
Market Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 472.49B, an increase of 128.74%. That is a compound annual growth rate of 34.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 472.49B | 4.20% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curocell | 786.56B |
| IntoCell | 762.61B |
| HansBiomed | 691.59B |
| curacle co.,ltd. | 393.72B |
| Y-Biologics | 388.56B |
| NIBEC | 364.28B |
| ABION | 284.27B |
| Genome & Company | 221.92B |